Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 261-270 of 290 for

Edit search filters
  1. Digital Biomarker And Omics-Based Assessment Of Surgical Resiliency In Children Undergoing Solid Tumor Resection

    Rochester, MN

  2. Collection of Lung Tumor Tissue for Current and Future Investigations into Lung Cancer Biology, Pathophysiology, and Epidemiology

    Jacksonville, FL

  3. Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy

    Rochester, MN

  4. Surgical Drain Fluid for Detection of Molecular Residual Disease in Patients With Non-small Cell Lung Cancers

    Rochester, MN

  5. A Study to Predict Lung Cancer Using Noninvasive Biomarkers

    Rochester, MN

  6. A Study to Explore the Effects of the Measles Virus on Tumor Immunity

    Rochester, MN

  7. Tumor Heterogeneity of the Tumor Microenvironment in Malignant Pleural Mesothelioma (MPM)

    Rochester, MN

  8. Treatment of Multifocal Lung Adenocarcinoma

    Rochester, MN

  9. A Study of an Integrated Approach to Treating Recurrent Lung Adenocarcinomas Resistant to Tyrosine Kinase Inhibitors

    Rochester, MN

  10. A Study to Evaluate Screening Biomarkers for Lung Cancer

    Jacksonville, FL

.

Mayo Clinic Footer